VERASTEM INC's ticker is VSTM and the CUSIP is 92337C104. A total of 132 filers reported holding VERASTEM INC in Q4 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $6 | 0.0% | 15,626 | 0.0% | 0.00% | – |
| Q4 2022 | $6 | -100.0% | 15,626 | 0.0% | 0.00% | – |
| Q3 2022 | $13,000 | -27.8% | 15,626 | 0.0% | 0.00% | – |
| Q2 2022 | $18,000 | -18.2% | 15,626 | 0.0% | 0.00% | – |
| Q1 2022 | $22,000 | +15.8% | 15,626 | +67.5% | 0.00% | – |
| Q4 2021 | $19,000 | -32.1% | 9,327 | +1.4% | 0.00% | – |
| Q3 2021 | $28,000 | -28.2% | 9,200 | -5.2% | 0.00% | – |
| Q2 2021 | $39,000 | +178.6% | 9,700 | +61.7% | 0.00% | – |
| Q1 2021 | $14,000 | +16.7% | 6,000 | 0.0% | 0.00% | – |
| Q4 2020 | $12,000 | +33.3% | 6,000 | -25.0% | 0.00% | – |
| Q3 2020 | $9,000 | -35.7% | 8,000 | 0.0% | 0.00% | – |
| Q2 2020 | $14,000 | -41.7% | 8,000 | -11.1% | 0.00% | – |
| Q1 2020 | $24,000 | +242.9% | 9,000 | +80.0% | 0.00% | – |
| Q4 2019 | $7,000 | +40.0% | 5,000 | +25.0% | 0.00% | – |
| Q3 2019 | $5,000 | – | 4,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 1,865,000 | $3,823,000 | 1.61% |
| Altium Capital Management LP | 2,253,000 | $4,619,000 | 1.27% |
| BVF INC/IL | 17,062,158 | $34,977,000 | 1.27% |
| MPM BioImpact LLC | 3,271,532 | $6,707,000 | 1.22% |
| Opaleye Management Inc. | 2,325,000 | $4,766,000 | 1.01% |
| Soleus Capital Management, L.P. | 1,644,500 | $3,371,000 | 0.34% |
| Baker Brothers Advisors | 21,491,630 | $44,058,000 | 0.21% |
| Ikarian Capital, LLC | 637,371 | $1,308,000 | 0.20% |
| Samalin Investment Counsel, LLC | 90,000 | $185,000 | 0.11% |
| Parkman Healthcare Partners LLC | 183,332 | $376,000 | 0.08% |